Clinical Research Directory
Browse clinical research sites, groups, and studies.
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV
Sponsor: University of Massachusetts, Worcester
Summary
Six million Americans live with atrial fibrillation (AF), a heart rhythm abnormality that is a major risk factor for stroke and only half of those AF patients receive oral anticoagulation (AC). Within the context of an ongoing collaboration between two large learning health systems, the investigators propose to study the impact of a shared clinical decision support tool embedded within the electronic health record designed to enhance guideline-based AC prescription. The hypothesis the investigators are testing is that the number of AC starts in patients seen by intervention providers will be higher than in patients seen by control providers. Additionally, the investigators are testing the hypothesis that the risk of not persisting on AC will be higher in the patients of control providers compared with patients of intervention providers.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
5094
Start Date
2022-12-15
Completion Date
2028-06-30
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
Best practice advisory (BPA)
For patients who are not on oral anticoagulation (AC) but have elevated stroke risk, the practice advisory will "fire," which is to say it will be active in the providers workflow during outpatient encounters with a patient's primary care provider (PCP) or cardiology provider.
Locations (2)
University of Florida College of Medicine - Jacksonville
Jacksonville, Florida, United States
UMass Chan Medical School
Worcester, Massachusetts, United States